Results 81 to 90 of about 6,917,354 (302)

Liquid chromatographic determination of enantiomeric purity of [11C]methyl-L-methionine and O-(2-[18F]fluoroethyl)-L-tyrosine by pre-column derivatization with o-phthaldialdehyde and N-isobutyryl-L-cysteine

EJNMMI Radiopharmacy and Chemistry
Background [11C]methyl-L-methionine ([11C]MET) and O-(2-[18F]fluoroethyl)-L-tyrosine ([18F]FET) are commonly used radiopharmaceuticals in positron emission tomography (PET) for diagnosis of brain tumors.
Viktória Forgács, Viktória Balla, Viktória Csonka, Dezső Szikra, Dániel Szücs, Enikő Németh, Zita Képes, György Trencsényi, István Jószai   +8 more
doaj   +1 more source

Nuclear medicine imaging in the evaluation of endocrine hypertension

Indian Journal of Endocrinology and Metabolism, 2012
Endocrine hypertension forms a small (< 5%) but curable subset of patients with hypertension. Common endocrine causes of hypertension include pheochromocytoma, Cushing′s syndrome, primary hyperaldosteronism, and thyroid disorders.
Punit Sharma, Rakesh Kumar
doaj   +1 more source

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

Molecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka, Wioleta Cieślik, Wojciech Płaziński, Katarzyna Stępnik, Anna Boguszewska‐Czubara, Elżbieta Kot, Robert Musioł, Mateusz Jasica, Anna Mrozek‐Wilczkiewicz, Katarzyna Malarz   +9 more
wiley   +1 more source

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

Molecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq, Marc Terrones, Felicia Rodrigues Fortes, Anne Schepers, Alessia Denis, Christophe Deben, Ken Op de Beeck, Guy Van Camp, Geert Vandeweyer   +8 more
wiley   +1 more source

Physics in nuclear medicine

, 2012
Physics in Nuclear Medicine - by Drs. Simon R. Cherry, James A. Sorenson, and Michael E. Phelps - provides current, comprehensive guidance on the physics underlying modern nuclear medicine and imaging using radioactively labeled tracers. This revised and
Sorenson, James A., Phelps, Michael E, Cherry, Simon R., Cherry, Simon R, Sorenson, James A, Phelps, Michael E.   +5 more
core  

Preoperative circulating tumor cells integrated with imaging analysis for prognostic evaluation in head and neck squamous cell carcinoma

Molecular Oncology, EarlyView.
Detecting circulating tumor cells (CTCs) in blood before surgery may help predict outcomes in patients with head and neck squamous cell carcinoma (HNSCC). Here, we show when combined with tumor size and lymph node involvement from routine imaging, CTC status identifies high‐risk patients with poorer survival—offering a simple, minimally invasive tool ...
Susanne Flach, Gizem Abaci, Tom Huberty, Axel Lechner, Lukas Käsmann, Jens Ricke, Sophia Stöcklein, Martin Canis, Philipp Baumeister, Marianna Alunni‐Fabbroni   +9 more
wiley   +1 more source

Single photon γ-ray imaging with high energy and spatial resolution perovskite semiconductor for nuclear medicine

Nature Communications
Integrating semiconductor detectors with high energy and spatial resolution is vital for advancing nuclear medicine imaging. Perovskite semiconductors afford unprecedented opportunity for reshaping radiation detection technologies.
Nannan Shen, Xuchang He, Tingting Gao, Bao Xiao, Yuquan Wang, Ruohan Ren, Haoming Qin, Khasim Saheb Bayikadi, Zhifu Liu, J. A. Peters, Bruce W. Wessels, Luyao Wang, Xiao Ouyang, Shuquan Wei, Qihao Sun, Xueping Liu, Yifei Lai, Xiaoping Ouyang, Zhifang Chai, Mercouri G. Kanatzidis, Yihui He   +20 more
doaj   +1 more source

State of affairs of hybrid imaging in Europe: two multi-national surveys from 2017

Insights into Imaging, 2019
Objectives To assess the current state of hybrid imaging in Europe with respect to operations, reading and reporting, as well as qualification and training.
Sergios Gatidis, Thomas Beyer, Minerva Becker, Katrine Riklund, Konstantin Nikolaou, Clemens Cyran, Christina Pfannenberg   +6 more
doaj   +1 more source

Epigenetic silencing of the liver‐specific lncRNA LUNAR promotes liver cancer progression via NOTCH activation

Molecular Oncology, EarlyView.
LUNAR is a liver‐specific long noncoding RNA (lncRNA) that is highly expressed in normal liver but becomes epigenetically silenced in hepatocellular carcinoma through promoter hypermethylation. Loss of LUNAR is associated with NOTCH activation, epithelial–mesenchymal transition, and metastasis, whereas restoring LUNAR restrains metastatic progression ...
Se Ha Jang, Hyung Seok Kim, Geum Ok Baek, Moon Gyeong Yoon, Su In Lee, Jee‐Yeong Jeong, Ji Eun Han, Soon Sun Kim, Jae Youn Cheong, Jung Woo Eun   +9 more
wiley   +1 more source

PANoptosis in the pathogenesis of myelodysplastic syndromes

Molecular Oncology, EarlyView.
PANoptosis, a combination of three types of programmed cell death, is mediated by a large protein complex called a PANoptosome. In healthy bone marrow hematopoietic cells, PANoptosis is restricted by inhibitory signaling. In MDS, bone marrow cells become sensitive to the PANoptotic stimuli due to the aberrant inactivation of inhibitory signaling or ...
Rohit Thalla, Jyoti Lamichhane, Cameron Lewis, Peter Breslin, Jiwang Zhang   +4 more
wiley   +1 more source